Home / Congress Presentations / C3G and IC-MPGN / Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024
Landing
Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024
Efficacy of 12-week pegcetacoplan in kidney transplant recipients with recurrent C3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN)
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.